Continued enzalutamide plus docetaxel offers clinical benefit for mCRPC patients who progress on enzalutamide Presented ByDr Axel Merseburger, Universitätsklinikum Schleswig-Holstein, Germany TrialPhase 3, PRESIDE ConferenceASCO GU 2022 8 April, 2022 11:24
ASCO GU 2022 Highlights Podcast Presented ByDr Rachel Giles, Medicom ConferenceASCO GU 2022 14 March, 2022 07:21